Corrigendum to “Comparison of glucagons like peptide-1 receptor agonists and dipeptidyl peptide-4 inhibitors regarding cardiovascular safety and mortality in type 2 diabetes mellitus: A network meta-analysis” [Prim. Care Diabetes 15 (April (2)) (2021) 227–233] |
| |
摘 要: |
|
本文献已被 ScienceDirect 等数据库收录! |
|